Journal List > Int J Thyroidol > v.10(2) > 1082712

Kim, Hwangbo, Kong, Song, Kim, Cho, Lee, Yi, Park, Lee, and Park: Secular Trends for Diagnostic Motives and Environmental Risk Factors in Thyroid Cancer Using Questionnaire Survey

Abstract

Background and Objectives

We analyzed the clinicopathologic differences of thyroid cancer by diagnosis periods, diagnostic motives, residence history and clinical risk factors in thyroid cancer patients.

Materials and Methods

Total 1599 thyroid cancer patients who answered the questionnaires about family history of thyroid cancer, residence history including duration of residence and location were enrolled from two hospitals, Seoul National University Hospital and National Cancer Center in Korea. Demographics and environmental information were collected via questionnaires and clinical data were reviewed via electronic medical records.

Results

More thyroid cancer has been diagnosed in 2011 to 2013 by screening test without specific symptom than before 1990. The size of cancer at diagnosis was significantly smaller and multifocal tumor was more frequently found in 2011 to 2013 than before 1990 as well. The tumors of obese or overweight patients tended to harbor extrathyroidal extension and lymph node metastasis than normal weight subjects with statistical significance. However, there were no differences in clinicopathologic characteristics according to residence and smoking history.

Conclusion

In this study, there were some different clinicopathologic characteristics according to the diagnosis era, diagnostic motives, family history of thyroid cancer and body mass index.

Figures and Tables

Fig. 1

Difference in diagnosis motivation according to periods.

ijt-10-82-g001
Table 1

Characteristics of subjects by diagnosis period

ijt-10-82-i001

BMI: body mass index, FTC: follicular thyroid cancer, LN: lymph node, LT: lobectomy, PTC: papillary thyroid cancer, SD: standard deviation, TT: total thyroidectomy

*Others included medullary thyroid cancer, poorly differentiated thyroid cancer and anaplastic thyroid cancer.

Table 2

Clinicopathological characteristics according to diagnosis motive

ijt-10-82-i002

LN: lymph node, PTC: papillary thyroid cancer, SD: standard deviation

Table 3

Clinicopathological characteristics according to residence

ijt-10-82-i003

ETE: extrathyroidal extension, LN: lymph node, PTC: papillary thyroid cancer, SD: standard deviation

Table 4

Clinicopathological characteristics according to family history of thyroid cancer

ijt-10-82-i004

ETE: extrathyroidal extension, LN: lymph node, PTC: papillary thyroid cancer, SD: standard deviation

Table 5

Clinicopathological characteristics according to smoking status

ijt-10-82-i005

ETE: extrathyroidal extension, LN: lymph node, PTC: papillary thyroid cancer, SD: standard deviation

Table 6

Clinicopathological characteristics according to body mass index

ijt-10-82-i006

BMI: body mass index, ETE: extrathyroidal extension, LN: lymph node, PTC: papillary thyroid cancer, SD: standard deviation

Acknowledgments

This work was supported by a grant from Research Grants No. 1410640-3, 1710430-1 to Eun Kyung Lee from the National Cancer Center.

References

1. Jung KW, Won YJ, Oh CM, Kong HJ, Lee DH, Lee KH. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2014. Cancer Res Treat. 2017; 49(2):292–305.
crossref
2. Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol. 2013; 2013:965212.
crossref
3. Kilfoy BA, Zheng T, Holford TR, Han X, Ward MH, Sjodin A, et al. International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control. 2009; 20(5):525–531.
crossref
4. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006; 295(18):2164–2167.
crossref
5. Liu S, Semenciw R, Ugnat AM, Mao Y. Increasing thyroid cancer incidence in Canada, 1970-1996: time trends and age-period-cohort effects. Br J Cancer. 2001; 85(9):1335–1339.
crossref
6. Nikiforov YE, Fagin JA. Risk factors for thyroid cancer. Trends Endocrinol Metab. 1997; 8(1):20–25.
crossref
7. Ahn HY, Park YJ. Incidence and clinical characteristics of thyroid cancer in Korea. Korean J Med. 2009; 77(5):537–542.
8. Feldt-Rasmussen U. Iodine and cancer. Thyroid. 2001; 11(5):483–486.
crossref
9. Nagataki S, Nystrom E. Epidemiology and primary prevention of thyroid cancer. Thyroid. 2002; 12(10):889–896.
crossref
10. Lind P, Langsteger W, Molnar M, Gallowitsch HJ, Mikosch P, Gomez I. Epidemiology of thyroid diseases in iodine sufficiency. Thyroid. 1998; 8(12):1179–1183.
crossref
11. Franceschi S. Iodine intake and thyroid carcinoma--a potential risk factor. Exp Clin Endocrinol Diabetes. 1998; 106:Suppl 3. S38–S44.
12. Cao LZ, Peng XD, Xie JP, Yang FH, Wen HL, Li S. The relationship between iodine intake and the risk of thyroid cancer: A meta-analysis. Medicine (Baltimore). 2017; 96(20):e6734.
13. Lee JH, Hwang Y, Song RY, Yi JW, Yu HW, Kim SJ, et al. Relationship between iodine levels and papillary thyroid carcinoma: A systematic review and meta-analysis. Head Neck. 2017; 39(8):1711–1718.
crossref
14. Lee HS, Min H. Iodine intake and tolerable upper intake level of iodine for Koreans. Korean J Nutr. 2011; 44(1):82–91.
crossref
15. Park YJ, Ahn HY, Choi HS, Kim KW, Park DJ, Cho BY. The long-term outcomes of the second generation of familial nonmedullary thyroid carcinoma are more aggressive than sporadic cases. Thyroid. 2012; 22(4):356–362.
crossref
16. Mazeh H, Benavidez J, Poehls JL, Youngwirth L, Chen H, Sippel RS. In patients with thyroid cancer of follicular cell origin, a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive disease. Thyroid. 2012; 22(1):3–8.
crossref
17. D'Avanzo B, La Vecchia C, Franceschi S, Negri E, Talamini R. History of thyroid diseases and subsequent thyroid cancer risk. Cancer Epidemiol Biomarkers Prev. 1995; 4(3):193–199.
18. Cho YA, Kim J. Thyroid cancer risk and smoking status: a meta-analysis. Cancer Causes Control. 2014; 25(9):1187–1195.
crossref
19. Iribarren C, Haselkorn T, Tekawa IS, Friedman GD. Cohort study of thyroid cancer in a San Francisco Bay area population. Int J Cancer. 2001; 93(5):745–750.
crossref
20. Engeland A, Tretli S, Akslen LA, Bjorge T. Body size and thyroid cancer in two million Norwegian men and women. Br J Cancer. 2006; 95(3):366–370.
crossref
21. Dal Maso L, La Vecchia C, Franceschi S, Preston-Martin S, Ron E, Levi F, et al. A pooled analysis of thyroid cancer studies. V. Anthropometric factors. Cancer Causes Control. 2000; 11(2):137–144.
22. Gallagher EJ, LeRoith D. Obesity and diabetes: the increased risk of cancer and cancer-related mortality. Physiol Rev. 2015; 95(3):727–748.
crossref
23. Braun S, Bitton-Worms K, LeRoith D. The link between the metabolic syndrome and cancer. Int J Biol Sci. 2011; 7(7):1003–1015.
crossref
24. Tsugane S, Inoue M. Insulin resistance and cancer: epidemiological evidence. Cancer Sci. 2010; 101(5):1073–1079.
crossref
TOOLS
Similar articles